This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Advance Directives or Bone Marrow Transplant
and you are
between 18 and 100
years old
-
The phase for this study is not defined.
Show me locations

The purpose

The purpose of the proposed research study is to evaluate whether bone marrow transplant patients prefer the Stanford letter advance care planning tool to the standard Advance directive. Completion of advance care planning prior to BMT is very important, but not often done. The investigators believe that the Stanford Letter will be preferred by patients and will allow them to feel more comfortable and share more of their wishes with family members and the medical team.

Provided treatments

  • Other: Stanford Letter
  • Other: Interview
  • Other: Questionnaire Administration
  • Other: CA Advance Health Care Directive Form
Tris trial is registered with FDA with number: NCT03028961. The sponsor of the trial is Stanford University and it is looking for 126 volunteers for the current phase.
Official trial title:
Randomized Clinical Study Comparing the Effectiveness of the Stanford Letter to the Traditional Advance Directive in Bone Marrow Transplant Recipients